Literature DB >> 19477887

The use of artificial nutrition among cancer patients enrolled in palliative home care services.

Y Orrevall1, C Tishelman, J Permert, T Cederholm.   

Abstract

In this study, patients' views and experiences of using home artificial nutrition, and factors associated with use of home parenteral nutrition (HPN) were investigated. Structured telephone interviews with 620 cancer patients enrolled in 21 palliative home care services were analysed. HPN was more common (11%) than home enteral tube feeding (HETF, 3%). Home artificial nutrition (including HPN and HETF) was usually introduced more than four months before death. Three of four HPN recipients also had oral food intake. HPN use was associated with eating difficulties, nausea/vomiting, and fatigue rather than gastrointestinal problems per se. HETF was generally used for patients with problems related to oesophagus and head and neck tumours. In conclusion the results suggest that, contrary to existing guidelines, HPN is used to supplement oral intake, and not only for patients with a non-functioning gastrointestinal tract.

Entities:  

Mesh:

Year:  2009        PMID: 19477887     DOI: 10.1177/0269216309105811

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  3 in total

Review 1.  Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider.

Authors:  Jessica Mitchell; Aminah Jatoi
Journal:  Semin Oncol       Date:  2011-06       Impact factor: 4.929

Review 2.  Nutrition interventions to treat low muscle mass in cancer.

Authors:  Carla M Prado; Sarah A Purcell; Alessandro Laviano
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-08       Impact factor: 12.910

3.  A national observational study of the prevalence and use of enteral tube feeding, parenteral nutrition and intravenous glucose in cancer patients enrolled in specialized palliative care.

Authors:  Ylva Orrevall; Carol Tishelman; Johan Permert; Staffan Lundström
Journal:  Nutrients       Date:  2013-01-22       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.